QSS
HAE icon

Quantitative Systematic Strategies’s Haemonetics HAE Stock Holding History

Quantitative Systematic Strategies’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-14,666
Closed -$1.63M – 548
2021
Q1 		$1.63M Buy
14,666
+918
+7% +$114K 0.25% 125
2020
Q4 		$1.63M Buy
+13,748
New +$1.48M 0.23% 143
2020
Q1 		– Sell
-2,676
Closed -$307K – 373
2019
Q4 		$307K Buy
2,676
+855
+47% +$103K 0.05% 438
2019
Q3 		$230K Buy
+1,821
New +$231K 0.05% 381
2016
Q1 		– Sell
-9,157
Closed -$301K – 561
2015
Q4 		$301K Buy
+9,157
New +$297K 0.08% 758

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.88B AUM 20.37% 1-Year Est. Return

Quantitative Systematic Strategies's HAE Position: Q2 2021 in Review

Quantitative Systematic Strategies sold out of Haemonetics (HAE) in Q2 2021, closing a stake of 14,666 shares — an estimated $1.63M sold.

Quantitative Systematic Strategies first reported a position in HAE in Q4 2015 and held it in 5 quarters. The position peaked at $1.63M in Q4 2020. 258 funds tracked by Wall St. Rank hold HAE as of Q2 2021.

  • Quantitative Systematic Strategies reported no remaining Haemonetics position as of Q2 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 14,666 Haemonetics shares in Q2 2021, an estimated $1.63M.
  • Quantitative Systematic Strategies first reported a position in Haemonetics in Q4 2015 and held it in 5 quarters.
  • Quantitative Systematic Strategies's Haemonetics position peaked at $1.63M in Q4 2020.
  • 258 funds tracked by Wall St. Rank held Haemonetics as of Q2 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2021, filed 5 Aug 2021.